Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000043

Drug Information
NameFurosemide    
SynonymsUNII-7LXU5N7ZO5; Oedemex; HMS2091H05; Odemase; KBio2_006716; Radonna; UPCMLD-DP022; Errolon; Lasix Retard; fulvamide; Urosemide; LB-502; HMS501M17; SMR000058202; Furosemide Monosodium Salt; Aquasin; Furfan; MolPort-001-641-065; Furosemide "mita"; 41733-55-5 (mono-hydrochloride salt); Farsix; Fusid; Franyl; Furosedon; BSPBio_002054; Edenol; Furosemide Monohydrochloride; Fuluvamine; Promedes; less Diur; Kofuzon; KBio1_000575; Frumide; Fursol; AC1Q557O; MLS001306403; Selectofur; HMS2090K06; Urex; Desal; SMP1_000129; Lazix; Marsemide; Fu sid; Laxur; BRD-K78010432-001-05-8; Furodrix; Salix; NINDS_000575; Polysquall A; SPBio_001129; WLN: T5OJ B1MR CG FVQ DSZW; CCRIS 1951; SPBio_002322; Furovite; Diuzol; STK177334; Dirine; Prestwick2_000341; Diumide-K; Trofurit; Katlex; Mirfat; Uridon; NCGC00090893-05; Synephron; Uremide; Furanturil; Fuluvamide; Golan; Sal diureticum; MLS001066374; Frusemin; Discoid; Furetic; Furosemide [USAN:INN:JAN]; NCGC00090893-03; CID3440; Furesis; Arasemide; D005665; Salinex; Beronald; EINECS 200-203-6; Salurid; Aisemide; Furomide M.D; Novosemide; Hoe-058A; CHEBI:47426; Lasix, Frusemide, Furosemide; Uresix; Furanthryl; NCGC00090893-02; Moilarorin; Radisemide; Frusenex; Yidoli; F4381_SIGMA; Jenafusid; Bio-0044; Puresis; 2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid; furosemide; Radouna; Furmid; BPBio1_000443; Furix; FUN; Luscek; Protargen; Transit; Prestwick3_000341; Liside; Spectrum4_000560; Vesix; Furex; Macasirool; Frusema; AC-11067; Hissuflux; Prefemin; Furosemidum; KBioGR_001259; CPD000058202; Furorese; BSPBio_000401; FUROSEMIDE USP; TL8003563; Apo-Frusemide; Impugan; Furosix; Profemin; KBioSS_001580; Furosemidu [Polish]; AC1L1FXW; CAS-54-31-9; S1603_Selleck; Uritol; Hydro; 54-31-9; Logirene; UPCMLD-DP022:001; Edemid; F0182; Disemide; 5-18-09-00555 (Beilstein Handbook Reference); Frusetic; Prestwick0_000341; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure; Endural; Prestwick_752; D00331; AKOS000266625; Anthranilic acid, 4-chloro-N-furfuryl-5-sulfamoyl-; Salurex; Hydroled; 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid; Lowpston; Frusedan; Frumex; C12H11ClN2O5S; Myrosemide; Desdemin; DB07799; Furosemidum [INN-Latin]; LB 502; Furantral; Retep; Hydrex; DB00695; Oprea1_667724; Furosemidu; Disal; Seguril; HSDB 3086; 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid; DivK1c_000575; Lasix (TN); Lasix; Frusid; Diusil; Bioretic; Eutensin; Lasilix; ARONIS24304; Diural; Hydro-rapid; LS-204; Fulsix; Zafimida; IDI1_000575; Spectrum5_000744; Furosemix; Prestwick1_000341; Furosemida; Fursemida; Eliur; Mita; Kutrix; Spirofur; Rosemide; Furobeta; Diurin; Fursemid; Urex-M; Rosis; Cetasix; SAM002264614; Spectrum2_001005; KBio2_001580; Lasex; Urian; Diurapid; Furomen; Fluidrol; Dryptal; Sigasalur; Furosemide (JP15/USP/INN); Lasemid; I04-0179; Nelsix; Aldalix; BIDD:GT0139; Furodiurol; Promide; Anfuramaide; Aldic; Furosan; Neo-renal; Durafurid; AB00052001; Odemex; Fluss; Furosemid; Furosifar; Furomide M.D.; Apo-Furosemide; furosemide ''mita''; Furoter; Furo-puren; Salix (brand of furosemide); Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure [German]; Furanthril; Furantril; Aluzine; NCI-C55936; NSC 269420; 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid; HMS1569E03; NSC269420; KBio2_004148; Frusemid; 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid; Diurolasa; NCGC00090893-01; Rusyde; Furocot; KBio3_001274; Furosemida [INN-Spanish]; Lowpstron; Aquarid; HMS1920B03; Dranex; Diusemide; BRN 0840915; Kolkin; Furo-Basan; NCGC00090893-06; Furomex; Furoside; Furose; Spectrum3_000437; NCGC00016241-01; CHEMBL35; Lasix Special; Spectrum_001100; Lasiletten; Fursemide; 4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid; Frusemide; SPECTRUM1500310; Depix; Nadis    
Trade NameAisemide; Apo-Furosemide; Beronald; Desdemin; Discoid; Diural; Diurapid; Dryptal; Durafurid; Errolon; Eutensin; Frusetic; Frusid; Fulsix; Fuluvamide; Furesis; Furix; Furo-Puren; Furosedon; Hydro-rapid; Impugan; Katlex; Lasilix; Lasix; Lodix; Lowpston; Macasirool; Mirfat; Nicorol; Odemase; Oedemex; Profemin; Rosemide; Rusyde; Salix; Trofurit; Urex; Frudix; Fusid    
CompanySanofi-Aventis    
IndicationEdema associated with congestive heart failureApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassDiuretics    
CAS NumberCAS 54-31-9
FormularC12H11ClN2O5S    
PubChem Compound IDCID 3440.    
PubChem Substance IDSID 140841.    
ChEBI47426;    
SuperDrug ATC IDC03CA01;    
SuperDrug CAS ID000054319;    
TargetNa+/K+/2CL-co-transporterBlocker[2]
Ref 1Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators. Rev Cardiovasc Med. 2008 Winter;9(1):39-45. To Reference
Ref 2Update of diuretics in the treatment of hypertension. Am J Ther. 2007 Mar-Apr;14(2):154-60. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543